Literature DB >> 6175654

Regulatory T cell-subset imbalance in chronic active hepatitis.

G Carella, L Chatenoud, F Degos, M A Bach.   

Abstract

Three monoclonal anti-T-cell antibodies, specifically directed against total T cells (OKT3), inducer-helper T cells (OKT4) and suppressor/cytotoxic T cells (OKT8), were used in this study to analyze peripheral T-cell subsets in hepatitis B surface antigen (HBsAg)-positive and -negative chronic active hepatitis (CAH) patients. Results showed that a clear-cut difference exists in the distribution of peripheral T cells of these two groups of subjects. HBsAg-positive CAH patients had a numerical predominance of peripheral T lymphocytes expressing the characteristics of cytotoxic/suppressor T cells. In contrast, patients with "autoimmune" HBsAg-negative CAH exhibit a predominance of OKT4 cells, namely, the helper-inducer T-cell subset. In addition, high numbers of circulating double labeled cells (expressing both the OKT4 and the OKT8 xenoantigens) were detected in some of the HBsAg-positive and HBsAg-negative CAH patients studied.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175654     DOI: 10.1007/BF00916892

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  31 in total

1.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Alteration in suppressor cell activity in chronic active hepatitis.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

3.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

4.  T cell subpopulations defined by monoclonal antibodies in autoimmune hemolytic anemia.

Authors:  F Phan-Dinh-Tuy; R Habibi; M A Bach; L Chatenoud; C Salmon; J F Bach
Journal:  Biomed Pharmacother       Date:  1983       Impact factor: 6.529

5.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

6.  The effect of immunosuppressive agents on T-cell subsets, as evaluated by use of monoclonal anti-T-cell antibodies.

Authors:  L Chatenoud; H Kreis; P Jungers; J F Bach
Journal:  Transplant Proc       Date:  1981-09       Impact factor: 1.066

7.  Further characterization of the human inducer T cell subset defined by monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

8.  Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease.

Authors:  G Husby; R G Strickland; J L Caldwell; R C Williams
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

9.  Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma.

Authors:  C Brechot; C Pourcel; A Louise; B Rain; P Tiollais
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

10.  Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.

Authors:  S Berrih; C Gaud; M A Bach; H Le Brigand; J P Binet; J F Bach
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

View more
  8 in total

1.  Lymphocyte subpopulations in patients with alcoholic liver disease.

Authors:  R Jovanovic; T Worner; C S Lieber; F Paronetto
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

2.  Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.

Authors:  G J Alexander; M Mondelli; N V Naumov; K T Nouriaria; D Vergani; D Lowe; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

3.  Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH).

Authors:  L S Si; T L Whiteside; R R Schade; D H Van Thiel
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

4.  Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load.

Authors:  Jing You; Lin Zhuang; Yi-Feng Zhang; Hong-Ying Chen; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Teerha Piratvisuth; Edward McNeil; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

5.  Elevated serum interleukin-6 levels in patients with acute hepatitis.

Authors:  Y Sun; K Tokushige; E Isono; K Yamauchi; H Obata
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

6.  Cellular immune responses in the acute exacerbation of hepatitis B e antigen-positive type B chronic hepatitis.

Authors:  I Hyodo; G Yamada; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1985-08

7.  Flow cytometry CD4+/CD8+ ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B.

Authors:  B N Pham; J F Mosnier; F Walker; C Njapoum; F Bougy; C Degott; S Erlinger; J H Cohen; F Degos
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

8.  Two-dimensional flow cytometric analysis of intrahepatic lymphocyte subsets from patients with chronic hepatitis.

Authors:  T Takehara; N Hayashi; K Katayama; A Kasahara; H Fusamoto; M Kato; M Masuzawa; T Kamada
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.